Also known as: EINECS 233-113-0, Hydrogen bromide, anhydrous, Acide bromhydrique, Acido bromhidrico, Acido bromidrico (+5 more)
CAS 10035-10-6
Hydrobromic acid (CAS 10035-10-6) is a chemical substance with GHS signal word Danger; key hazard signal: H335; H314. Key regulatory status: REACH registered, 2 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from ECHA CLP, EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH, ILO ICSC, OSHA.
Hydrobromic acid is prohibited in EU cosmetics but has active industrial GHS classifications (H335, H314).
CAS, identifiers, formula, and alternate names for the matched substance record.
EU harmonized hazard classification, hazard statements, pictograms, and signal word.
| Hazard Class | H-Statements | Pictograms | Signal |
|---|---|---|---|
| Press. Gas; STOT SE 3; Skin Corr. 1A | H335; H314 | GHS04; GHS07; GHS05 | Danger |
International Chemical Safety Card hazard and exposure summary.
| Field | Value |
|---|---|
| Short-term Effects | The substance is corrosive to the eyes, skin and respiratory tract. Inhalation of this gas may cause lung oedema. See Notes. Rapid evaporation of the liquid may cause frostbite. |
| Routes of Exposure | The substance can be absorbed into the body by inhalation. |
Occupational exposure limits from OSHA, NIOSH, and ACGIH rows.
| Agency | Metric | Value | ppm | mg/m3 | Skin |
|---|---|---|---|---|---|
| OSHA | TWA | 3 ppm (10 mg/m³) | 3 | 10 | N |
| NIOSH | CEILING | 3 ppm (10 mg/m³) | 3 | 10 | N |
| ACGIH | CEILING | 2 ppm [2001] | 2 | - | N |
| CAL/OSHA | CEILING | 3 ppm (10 mg/m³) | 3 | 10 | N |
| NIOSH | IDLH | 30 ppm | 30 | - | - |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| detected; Toys and children's products | State of Washington Department of Ecology | State of Washington |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 2.28 | min | Breakthrough Time | Dermal | - | NTP_ICE_skin_irritation |
| 2.65 | min | Breakthrough Time | Dermal | - | NTP_ICE_skin_irritation |
| =6.7 | mg/m3 | DNEL local | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 3IY7CNP8XJ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3IY7CNP8XJ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3IY7CNP8XJ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 3IY7CNP8XJ | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 9.4521 | mg/L | LC50 | Inhalation | - | NTP_ICE_acute_inhalation |
| 9.4587 | mg/L | LC50 | Inhalation | - | NTP_ICE_acute_inhalation |
| 9.9217 | mg/L | LC50 | Inhalation | - | NTP_ICE_acute_inhalation |
| >9.9279 | mg/m3 | LOAEL | inhalation | Human | ToxValDB_EU_SCOEL |
| <13.2372 | mg/m3 | LOAEL | inhalation | Human | ToxValDB_EU_SCOEL |
| =6.6186 | mg/m3 | NOAEL | inhalation | Human | ToxValDB_EU_SCOEL |
| 2.9 | % | Viability (240 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 4.6 | % | Viability (240 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 5.9 | % | Viability (240 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 2.8 | % | Viability (3 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 4.1 | % | Viability (3 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 15.8 | % | Viability (3 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 3.2 | % | Viability (60 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 4.2 | % | Viability (60 minutes) | Dermal | - | NTP_ICE_skin_irritation |
| 16.4 | % | Viability (60 minutes) | Dermal | - | NTP_ICE_skin_irritation |
Showing 22 of 22 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | Hydrogen bromide | 233-113-0 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Hydrobromic acid (CAS 10035-10-6) is classified under EU CLP Annex VI as Press. Gas; STOT SE 3; Skin Corr. 1A with signal word Danger. Hazard statements: H335; H314. Source: EU CLP Annex VI (ECHA).
Hydrobromic acid has 22 NOAEL studies in the database. The lowest reported value is 2.28 min via Dermal. Source: NTP_ICE_skin_irritation.
Hydrobromic acid appears on 2 regulatory/inventory lists including detected; Toys and children's products, inert_ingredient; non_food_use; Pesticides. Source: EPA CPDat.
Occupational exposure limits for Hydrobromic acid are set by OSHA, NIOSH, ACGIH. 5 limit values from official agencies are documented in the database. Source: OSHA, NIOSH, ACGIH.
Yes, Hydrobromic acid is also indexed as a cosmetic ingredient under the name Hydrobromic Acid. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from ECHA CLP Annex VI, EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, ILO/WHO ICSC, OSHA/NIOSH/ACGIH, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Hydrobromic acid is prohibited in EU cosmetics but has active industrial GHS classifications (H335, H314).
Hydrobromic acid also appears in cosmetics, pharmaceutical databases.